Process for extracting astaxanthin pigment from yeast and extracted pigment thereof

The present invention relates to a process for extracting astaxanthin pigment from the yeast cells of comprising the steps of i) cultivating the yeast, ii) treating yeast culture suspension with microwave to destroy the cell walls and mi...

YH Ji，SJ Lee，MK Jung，... - EP

Therapeutic potential of siRNA and DNAzymes in cancer

Cancer is characterized by uncontrolled cell growth, invasion, and metastasis and possess threat to humans worldwide. The scientific community is facing nu...

HK Karnati，RS Yalagala，R Undi，... - 《Tumour Biology the Journal of the International Society for Oncodevelopmental Biology & Medicine》

POLYNUCLEOTIDES FOR MULTIVALENT RNA INTERFERENCE, COMPOSITIONS AND METHODS OF USE THEREOF

The present invention includes bivalent or multivalent nucleic acid molecules or complexes of nucleic acid molecules having two or more target-specific regions, in which the target-specific regions are complementary to a single target ge...

HAUSER, Todd, M.

Anticancer agents; genetic engineering; monoclonal antibodies

The present invention relates to antibodies, which are directed to the human IGF-1 receptor (IGF-1R) and are to be administered for the treatment of cancer...

BD Cohen，V Bedian - US

Modified IL-4 mutein receptor antagonists

This invention relates to modified IL-4 mutein receptor antagonists comprising an IL-4 mutein receptor antagonist coupled to polyethylene glycol. Related formulations and dosages and methods of administration thereof for therapeutic purp...

BOISVERT, David，BURMEISTER-GETZ, Elise，DELARIA, Kathy，... - US

Plant disease controlling composition and method for controlling plant disease

The present invention provides a composition having an excellent controlling activity on plant disease. The composition comprising the compound represented by the formula (1) and one or more carbamate fungicidal compound selected from th...

SM Masana - US

BIOMARKERS FOR IGF-1R INHIBITOR THERAPY

The invention concerns the identification and validation of certain biomarkers for selecting patients for therapy with an IGF-1R inhibitor, particularly fo...

MR Lackner

BIOMARKERS FOR IGF-1R INHIBITOR THERAPY

The invention concerns the identification and validation of certain biomarkers for selecting patients for therapy with an IGF-1R inhibitor, particularly fo...

MR Lackner

Therapeutic potential of siRNA and DNAzymes in cancer.

Cancer is characterized by uncontrolled cell growt

HK Karnati，RS Yalagala，R Undi，... - 《Tumour Biology the Journal of the International Society for Oncodevelopmental Biology & Medicine》

Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one...

JE Monahan，S Hoersch，DL Anderson，... - US